Search results for "Immunological"

showing 10 items of 115 documents

Mucosal immunity in Crohn's disease.

2004

Crohn's diseaseCrohn Diseasebusiness.industryImmunologyGastroenterologymedicineModels ImmunologicalImmunology and AllergyHumansmedicine.diseasebusinessMucosal immunityImmunity MucosalInflammatory bowel diseases
researchProduct

Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults

2015

Objective: The prevalence of overweight and obesity is increasing among HIV-infected patients. Whether standard antiretroviral drug dosage is adequate in heavy individuals remains unresolved. We assessed the virological and immunological responses to initial efavirenz (EFV)-containing regimens in heavy compared to normal-weight HIV-infected patients. Design: Observational European cohort collaboration study. Methods: Eligible patients were antiretroviral-naive with documented weight prior to EFV start and follow-up viral loads after treatment initiation. Cox regression analyses evaluated the association between weight and time to first undetectable viral load ( 50 copies/ml) after initial s…

CyclopropanesMaleEfavirenz; HIV; Immunological response; Virological response; Weight; Adult; Antiretroviral Therapy Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; Male; Middle Aged; Obesity; Regression Analysis; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Body WeightHIV InfectionsOverweight10234 Clinic for Infectious DiseasesCohort Studieschemistry.chemical_compoundAntiretroviral Therapy Highly ActiveImmunology and AllergyHIV InfectionImmunological responsevirus diseasesVirological responseMiddle AgedViral LoadReverse Transcriptase InhibitorTreatment OutcomeInfectious DiseasesAlkynesCohort2723 Immunology and AllergyRegression AnalysisReverse Transcriptase InhibitorsFemalemedicine.symptomViral loadCohort studyHumanBenzoxazineAdultmedicine.medical_specialtyEfavirenzImmunologyAntiretroviral Therapy610 Medicine & healthRegression AnalysiPharmacokineticsInternal medicinemedicineHumansHighly ActiveObesity2403 Immunologybusiness.industryProportional hazards modelBody WeightHIV2725 Infectious DiseasesEfavirenz; HIV; Immunological response; Virological response; Weight; Adult; Antiretroviral Therapy Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; Male; Middle Aged; Obesity; Regression Analysis; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Body Weight; Immunology and Allergy; Immunology; Infectious Diseasesmedicine.diseaseWeightObesityBenzoxazinesCD4 Lymphocyte Countlnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]chemistryImmunologyCohort StudieEfavirenzbusiness
researchProduct

Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia

2021

BackgroundT-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease with a poor cure rate for relapsed/resistant patients. Due to the lack of T-cell restricted targetable antigens, effective immune-therapeutics are not presently available and the treatment of chemo-refractory T-ALL is still an unmet clinical need. To develop novel immune-therapy for T-ALL, we generated an afucosylated monoclonal antibody (mAb) (ahuUMG1) and two different bispecific T-cell engagers (BTCEs) against UMG1, a unique CD43-epitope highly and selectively expressed by T-ALL cells from pediatric and adult patients.MethodsUMG1 expression was assessed by immunohistochemistry (IHC) on a wide panel of normal t…

Cytotoxicity ImmunologicCancer Research2434T-LymphocytesMice SCIDafucosylated monoclonal antibodyLymphocyte ActivationPrecursor T-Cell Lymphoblastic Leukemia-LymphomaEpitopesJurkat CellsAntineoplastic Agents ImmunologicalAntibody SpecificityMice Inbred NODantigensAntibodies BispecificTumor MicroenvironmentImmunology and Allergyantibodieshematologic neoplasms1506RC254-282Antibody-dependent cell-mediated cytotoxicityLeukosialinbispecific T-cell engagersmedicine.diagnostic_testbiologyhematological malignancieNeoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.anatomical_structureantibodieOncologytranslational medical researchMolecular MedicineImmunohistochemistryFemaleimmunotherapyAntibodyT-ALLT-cell engagersT-cell acute lymphoblastic leukemiamedicine.drug_classT cellImmunologySettore MED/08 - Anatomia PatologicaMonoclonal antibodyAntibodies Monoclonal HumanizedFlow cytometryT Acute Lymphoblastic LeukemiaantigenAntigenPhagocytosismedicineAnimalsHumanshematological malignanciesCell ProliferationPharmacologyT-cell engagerbusiness.industryhematological malignancies; antibodies; antigens; hematologic neoplasms; immunotherapy; neoplasm; T-ALL; T-cell engagers; translational medical research; translational researchBasic Tumor ImmunologyXenograft Model Antitumor Assaystranslational researchCancer researchbiology.proteinneoplasmbusinesshematologic neoplasmneoplasm
researchProduct

Regulatory T cells--the renaissance of the suppressor T cells.

2007

Immune reactions are stringently regulated and balanced by complex interactions of stimulating and suppressing mechanisms. Dysfunctions of this sophisticated immune regulatory network can lead to a variety of diseases such as autoimmunity, allergy, cancer, and pregnancy disorders. The rediscovery of suppressor T cells a decade ago--now designated as T regulatory cells--set off a huge avalanche of research activities leading to a multitude of preclinical and clinical studies. Herein, we give a comprehensive review about this research on T regulatory cells and the relevance of this suppressive T cell population for the development of innovative immune therapeutic strategies.

Encephalomyelitis Autoimmune Experimentalmedicine.medical_treatmentT cellPopulationAutoimmunitymedicine.disease_causeInfectionsT-Lymphocytes RegulatoryAutoimmunitylaw.inventionMiceImmune systemlawPregnancyT-Lymphocyte SubsetsTransplantation ImmunologyNeoplasmsmedicineSuppressor Factors ImmunologicAnimalsHumanseducationeducation.field_of_studybusiness.industryModels ImmunologicalGeneral MedicineT lymphocyteImmunotherapyInflammatory Bowel DiseasesTransplantationDisease Models Animalmedicine.anatomical_structureDiabetes Mellitus Type 1ImmunologySuppressorFemaleImmunotherapybusinessAnnals of medicine
researchProduct

Squaric Acid Mediated Synthesis and Biological Activity of a Library of Linear and Hyperbranched Poly(Glycerol)-Protein Conjugates

2012

Polymer-protein conjugates generated from side chain functional synthetic polymers are attractive because they can be easily further modified with, for example, labeling groups or targeting ligands. The residue specific modification of proteins with side chain functional synthetic polymers using the traditional coupling strategies may be compromised due to the nonorthogonality of the side-chain and chain-end functional groups of the synthetic polymer, which may lead to side reactions. This study explores the feasibility of the squaric acid diethyl ester mediated coupling as an amine selective, hydroxyl tolerant, and hydrolysis insensitive route for the preparation of side-chain functional, …

GlycerolModels MolecularCovalent AttachmentPolymers and PlasticsPolymersBioengineeringSquaric acidImmunological PropertiesLigandsSmall Molecule LibrariesBiomaterialsHydrolysischemistry.chemical_compoundResidue (chemistry)Thiazolidine-2-ThioneMaterials ChemistrySide chainCopolymerOrganic chemistryBovine Serum-Albuminchemistry.chemical_classificationPoly(Ethylene Glycol)Molecular StructureCopolymersPolymer StructureSerum Albumin BovinePolymerPolyethylene-GlycolMolecular WeightPolyglycerolschemistryMuramidaseAmine gas treatingFunctional polymersCyclobutanesDerivatives
researchProduct

Insect immunity: oral exposure to a bacterial pathogen elicits free radical response and protects from a recurring infection

2014

Background: Previous exposure to a pathogen can help organisms cope with recurring infection. This is widely recognised in vertebrates, but increasing occasions are also being reported in invertebrates where this phenomenon is referred to as immune priming. However, the mechanisms that allow acquired pathogen resistance in insects remain largely unknown. Results: We studied the priming of bacterial resi stance in the larvae of the tiger moth, Parasemia plantaginis using two gram-negative bacteria, a pathogenic Serratia marcescens and a non-pathogenic control, Escherichia coli. Asublethaloraldoseof S. marcescens provided the larvae with effective protection against an otherwise lethal septic…

Gram-negative bacteriaimmune primingDefence mechanismsBacterial resistanceMicrobiology03 medical and health sciencesImmune systemAntibiotic resistanceImmunityParasemia plantaginisimmunological loiteringPathogenSerratia marcescensEcology Evolution Behavior and Systematics030304 developmental biologyinsect immunityreactive oxygen species0303 health sciencesbiology030306 microbiologyResearchImmunological loiteringfungibacterial resistancebiology.organism_classificationGram-negativegram-negativeInsect immunitySerratia marcescensImmunologyparasemia plantaginisParasemia plantaginisAnimal Science and ZoologyImmune primingReactive oxygen speciesFrontiers in Zoology
researchProduct

Revisiting Current Concepts on the Tolerogenicity of Steady-State Dendritic Cell Subsets and Their Maturation Stages

2021

Abstract The original concept stated that immature dendritic cells (DC) act tolerogenically whereas mature DC behave strictly immunogenically. Meanwhile, it is also accepted that phenotypically mature stages of all conventional DC subsets can promote tolerance as steady-state migratory DC by transporting self-antigens to lymph nodes to exert unique functions on regulatory T cells. We propose that in vivo 1) there is little evidence for a tolerogenic function of immature DC during steady state such as CD4 T cell anergy induction, 2) all tolerance as steady-state migratory DC undergo common as well as subset-specific molecular changes, and 3) these changes differ by quantitative and qualitati…

Immunity CellularSteady state (electronics)Cd4 t cellImmunologyModels ImmunologicalAutoimmunityCell DifferentiationDendritic CellsDendritic cellBiologyT-Lymphocytes RegulatoryCell biologyCell MovementImmune ToleranceAnimalsHumansImmunology and AllergyFunction (biology)The Journal of Immunology
researchProduct

Cytoskeletal stabilization of inhibitory interactions in immunologic synapses of mature human dendritic cells with natural killer cells

2011

Abstract Human mature dendritic cells (DCs) can efficiently stimulate natural killer (NK)–cell responses without being targeted by their cytotoxicity. To understand this important regulatory crosstalk, we characterized the development of the immunologic synapse between mature DCs and resting NK cells. Conjugates between these 2 innate leukocyte populations formed rapidly, persisted for prolonged time periods and matured with DC-derived f-actin polymerization at the synapse. Polarization of IL-12 and IL-12R to the synapse coincided with f-actin polymerization, while other activating and inhibitory molecules were enriched at the interface between DCs and NK cells earlier. Functional assays re…

Immunological SynapsesImmunologyCell Communicationmacromolecular substancesBiochemistryImmunological synapseNatural killer cell03 medical and health sciences0302 clinical medicineInterleukin-15 Receptor alpha SubunitMicroscopy Electron TransmissionReceptors KIRMHC class ImedicineHumansAntigen-presenting cellCells CulturedCytoskeleton030304 developmental biology0303 health sciencesMicroscopy ConfocalbiologyReceptors Interleukin-12Dendritic CellsCell BiologyHematologyDendritic cellFlow CytometryInterleukin-12Immunological SynapsesActinsCoculture Techniques3. Good healthCell biologyKiller Cells Naturalmedicine.anatomical_structureMicroscopy Fluorescencebiology.proteinInterleukin 12RNA InterferenceK562 CellsMicrotubule-Organizing CenterWiskott-Aldrich Syndrome Protein030215 immunologyK562 cellsBlood
researchProduct

SARS-CoV-2 in patients with cancer: possible role of mimicry of human molecules by viral proteins and the resulting anti-cancer immunity

2021

AbstractA few reports suggest that molecular mimicry can have a role in determining the more severe and deadly forms of COVID-19, inducing endothelial damage, disseminated intravascular coagulation, and multiorgan failure. Heat shock proteins/molecular chaperones can be involved in these molecular mimicry phenomena. However, tumor cells can display on their surface heat shock proteins/molecular chaperones that are mimicked by SARS-CoV-2 molecules (including the Spike protein), similarly to what happens in other bacterial or viral infections. Since molecular mimicry between SARS-CoV-2 and tumoral proteins can elicit an immune reaction in which antibodies or cytotoxic cells produced against t…

Immunological cross-reactionMini ReviewShared epitopesmedicine.disease_causeBiochemistryVirusViral ProteinsImmunityNeoplasmsHeat shock proteinmedicineHumansCytotoxic T cellCancerDisseminated intravascular coagulationbiologySARS-CoV-2Molecular MimicryfungiImmunityCOVID-19CancerCell Biologymedicine.diseaseMolecular mimicrybiology.proteinCancer researchAntibodyCOVID-19 . SARS-CoV-2 . Cancer . Molecularmimicry . Shared epitopes . Immunological cross-reaction
researchProduct

Stalemating a clever opportunist: lessons from murine cytomegalovirus.

2003

Abstract Cytomegaloviruses and their specific hosts have come to an arrangement that avoids disease but allows the viruses to persist in the individual host and to spread in the host species. Recent work has uncovered some of the molecular details of this evolutionary “contract for mutual survival.” Cytomegaloviruses encode proteins, referred to as “immunoevasins,” which are specifically committed to subvert the immune defense of the host for evading virus elimination. In reply, the hosts have evolved countermeasures to overcome the viral immunoevasins and present antigenic peptides to an extent that is sufficient for confining virus replication to below a harmful level. Accordingly, cytome…

ImmunologyAntigen presentationCongenital cytomegalovirus infectionDown-RegulationDiseaseImmunodominanceBiologyCD8-Positive T-LymphocytesMajor histocompatibility complexInterferon-gammaMiceViral ProteinsViral Envelope ProteinsmedicineImmunology and AllergyCytotoxic T cellAnimalsImmunologic SurveillanceGlycoproteinsAntigen PresentationMembrane GlycoproteinsCytomegalic inclusion diseaseHistocompatibility Antigens Class IModels ImmunologicalGeneral Medicinemedicine.diseaseVirologyPeptide FragmentsProtein TransportViral replicationCytomegalovirus Infectionsbiology.proteinCarrier ProteinsHuman immunology
researchProduct